These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19303544)

  • 1. [Diagnosis of irritable bowel syndrome].
    Coffin B
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S9-16. PubMed ID: 19303544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Irritable bowel syndrome: epidemiology/economic burden].
    Dapoigny M
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S3-8. PubMed ID: 19303536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of early diagnosis in patients with irritable bowel syndrome.
    Halpert AD
    Postgrad Med; 2010 Mar; 122(2):102-11. PubMed ID: 20203461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome.
    Whitehead WE; Palsson OS; Feld AD; Levy RL; VON Korff M; Turner MJ; Drossman DA
    Aliment Pharmacol Ther; 2006 Jul; 24(1):137-46. PubMed ID: 16803612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of irritable bowel syndrome: a community survey.
    Wilson S; Roberts L; Roalfe A; Bridge P; Singh S
    Br J Gen Pract; 2004 Jul; 54(504):495-502. PubMed ID: 15239910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
    Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
    Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
    Korkut E; Bektas M; Oztas E; Kurt M; Cetinkaya H; Ozden A
    Eur J Intern Med; 2010 Oct; 21(5):389-92. PubMed ID: 20816591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When to conduct testing in patients with suspected irritable bowel syndrome.
    Talley NJ
    Rev Gastroenterol Disord; 2003; 3 Suppl 3():S18-24. PubMed ID: 14502113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Societal costs for irritable bowel syndrome--a population based study.
    Hillilä MT; Färkkilä NJ; Färkkilä MA
    Scand J Gastroenterol; 2010 May; 45(5):582-91. PubMed ID: 20166844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
    Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Red flag" evaluation yield in irritable bowel syndrome.
    Black TP; Manolakis CS; Di Palma JA
    J Gastrointestin Liver Dis; 2012 Jun; 21(2):153-6. PubMed ID: 22720303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of irritable bowel syndrome among undergraduates in Southeast China.
    Dai N; Cong Y; Yuan H
    Dig Liver Dis; 2008 Jun; 40(6):418-24. PubMed ID: 18339591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
    Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
    Hillilä MT; Färkkilä MA
    Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
    Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of different diagnostic criteria for the irritable bowel syndrome among men and women.
    Hammer J; Talley NJ
    J Clin Gastroenterol; 2008 Feb; 42(2):160-6. PubMed ID: 18209586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of irritable bowel syndrome using a Rome II-based classification.
    Williams RE; Black CL; Kim HY; Andrews EB; Mangel AW; Buda JJ; Cook SF
    Aliment Pharmacol Ther; 2006 Jan; 23(1):197-205. PubMed ID: 16393298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course].
    Zwolińska-Wcisło M; Galicka-Latała D; Rozpondek P; Rudnicka-Sosin L; Mach T
    Przegl Lek; 2009; 66(3):126-9. PubMed ID: 19689036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.